CardioLogical Solutions Is “Accessorizing” a Potential $3 Billion Market by Making Transcatheter Aortic Valve Replacement “Truly Nonsurgical and Safer”
Privately held CardioLogical Solutions is an emerging cardiovascular company formed this month by the merger of Emboline and VasoStitch. The company is developing a comprehensive suite of technologies that address the three biggest, and most pressing, clinical needs in order to make transcatheter aortic valve replacement (TAVR) procedures truly percutaneous and safer.